Today: 30 June 2026
Xero share price dips after Melio-linked share issuance filing — what to watch next for XRO.AX
17 February 2026
1 min read

Xero share price dips after Melio-linked share issuance filing — what to watch next for XRO.AX

Sydney, Feb 17, 2026, 18:11 (AEDT) — Market wrapped up for the day

  • Xero slipped 0.7%, closing at A$78.50 this Tuesday.
  • The company highlighted a minor new-share quote connected to its Melio buyout in a filing with regulators.
  • Investors have their eyes on upcoming Melio-linked share releases, plus the next set of results due out in May.

Xero Ltd (XRO.AX) slipped 0.7% to close at A$78.50 on Tuesday, following its filing of updated ASX documents relating to newly issued shares connected to the Melio acquisition.

Investors haven’t let up on software names, holding them close after a turbulent stretch for global tech. Those wild swings? Blame the latest anxiety over AI spending and its impact on business models.

Xero’s fortunes are closely tied to wider swings in tech sentiment—call it “risk-on, risk-off.” The market’s still sorting out just how much of the company’s momentum will need to come from payments growth in the U.S., and whether it can deliver on Melio.

Xero, according to a filing, is seeking to list 61,445 ordinary shares that were issued on Feb. 17 as part of its acquisition of Melio Ltd—no cash changed hands for these shares. The same document flagged more shares potentially hitting the market from the transaction: 1,315,935 shares are set to exit voluntary escrow on April 15, 2026, opening up additional supply.

Xero shares surged 7.5% the previous day as local tech stocks rebounded, lifting the ASX information technology sector 5.6%. WiseTech Global and Technology One also posted strong gains in the same session.

Earlier this month, Xero pointed investors toward AI and payments as new areas of focus. CEO Sukhinder Singh Cassidy described the company as “deeply focused” on global AI as well as the U.S. “accounting plus payments” space—the kind of broad opportunity companies usually refer to as their total addressable market. Xero also confirmed its next update will come with its FY26 results on May 14, promising additional details on Melio and U.S. performance at that time.

Even so, the short-term tape isn’t likely to wait around. Fresh jitters in global tech? Those tend to land on high-multiple software stocks first. Plus, more shares hitting the market from acquisition-related sales—even if the numbers seem minor—can bump up supply.

Heading into the next ASX session, traders are set to watch if Tuesday’s dip signals more downside or simply distracts after Monday’s rebound. Melio-related filings remain a wildcard—any updates, particularly around the timing of new share issues, could grab attention fast.

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Stock Market Today

  • Bitcoin Drops Under $60,000 as Yen Sinks; Strategy Plans Share Buyback, BTC Sale
    June 30, 2026, 1:30 AM EDT. Bitcoin (BTC) fell under $60,000, sliding more than 1% while the Japanese yen dropped to a 40-year low against the dollar, rattling currency markets. BTC stayed below its 200-week simple moving average, a level traders watch. Strategy, known as the biggest publicly traded Bitcoin holder, said it wants to buy back $1 billion in shares and raise $1.25 billion by selling some of its BTC. That's a shift from founder Michael Saylor's old hold-for-the-long-term approach. Strategy's preferred stock (STRC) dropped sharply, hurting its ability to fund more BTC buys. Jeff Dorman at Arca said the company is pushing off an inevitable reckoning, and the move adds uncertainty to the market.
Uber stock: Tuesday test looms after Uber Eats targets $1 billion boost in Europe
Previous Story

Uber stock: Tuesday test looms after Uber Eats targets $1 billion boost in Europe

Eli Lilly stock pops after Novo trial miss, new Zepbound pen gets FDA nod
Next Story

Eli Lilly stock pops after Novo trial miss, new Zepbound pen gets FDA nod

Go toTop